Sensitization to radiation and alkylating agents was enhanced in DSB repair-deficient cells [33], consistent with the remarkable sensitivity to PARP inhibition of BRCA-1 and BRCA-2-deficient tumor cells [6]. The gene discussed is BRCA1; the disease is neoplasm.